Suppr超能文献

[哮喘或慢性阻塞性肺疾病患者支气管肺泡灌洗中淋巴细胞上黏附分子LFA-1(CD11a)和ICAM-1(CD54)的表达以及趋化因子IL-8和MCP-1的浓度]

[Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease].

作者信息

Jahnz-Rózyk K, Chciałowski A, Pirozyńska E, Rogalewska A

机构信息

Kliniki Chorób Wewnetrznych, Pneumonologii i Alergologii.

出版信息

Pol Merkur Lekarski. 2000 Oct;9(52):649-52.

Abstract

Chemokines and cellular adhesion molecules are crucial determinants of the migration of immune effector cells to the tissues asthma and chronic obstructive pulmonary disease (COPD) are a complex of conditions, which have airflow limitation in common. The aim of this study was to determine the numbers and percentages of lymphocytes expressing adhesion molecules: LFA-1, ICAM-1 together with assessment of chemokines concentrations: IL-8 and MCP-1 in bronchoalveolar lavage fluid (BAL) of patients with asthma or chronic obstructive pulmonary disease (COPD). 12 patients with asthma, 14 patients with COPD, and 6 subjects of control group took part in this study. The expression of LFA-1 and ICAM-1 was assessed on lymphocytes by using immunohistochemistry (streptavidyn-biotin, DAKO, Denmark). ELISA test was used to measure IL-8 and MCP-1 concentrations in BAL (kits from R&D, USA). The percentage of lymphocytes expressing LFA-1 and ICAM-1 were: 33.9 +/- 23.8% and 25.8 +/- 12.2% in COPD patients, 23.9 +/- 12.1% and 15.3 +/- 4.42% in asthma patients, and 14.2 +/- 10% and 5.2 +/- 1.6% in the control group respectively. There was observed significant difference between the percentage of lymphocytes expressing LFA-1 and ICAM-1 of COPD and the control group. The concentrations of IL-8 were: 2306 +/- 1501 pg/ml in COPD, 233 +/- 27.3 pg/ml in asthma and 64 +/- 28.7 in the control group (p < 0.05). The concentrations of MCP-1 were: 768.9 +/- 668.1 pg/ml in COPD, 126.8 +/- 30.8 pg/ml in asthma, and 83.0 +/- 16.4 pg/ml in the control group (p < 0.05). There was observed correlation between lymphocytes expressing LFA-1 and IL-8 concentration (r = +0.5, p < 0.05) and between lymphocytes expressing LFA-1 and MCP-1 concentration (r = +0.5, p < 0.05), and between lymphocytes expressing ICAM-1 and MCP-1 concentration (r = +0.4, p < 0.05) only in COPD patients. Our data suggest that LFA-1 and ICAM-1 are important molecules in the recruitment of leukocytes and together with IL-8 and MCP-1 may have a role in pathomechanism of inflammation in asthma and especially in COPD.

摘要

趋化因子和细胞黏附分子是免疫效应细胞向组织迁移的关键决定因素。哮喘和慢性阻塞性肺疾病(COPD)是一组复杂的病症,它们都存在气流受限的情况。本研究的目的是确定表达黏附分子LFA-1、ICAM-1的淋巴细胞数量和百分比,并评估哮喘或慢性阻塞性肺疾病(COPD)患者支气管肺泡灌洗液(BAL)中趋化因子浓度:白细胞介素-8(IL-8)和单核细胞趋化蛋白-1(MCP-1)。12例哮喘患者、14例COPD患者和6例对照组受试者参与了本研究。采用免疫组织化学法(链霉亲和素-生物素,丹麦DAKO公司)评估淋巴细胞上LFA-1和ICAM-1的表达。采用酶联免疫吸附测定(ELISA)法检测BAL中IL-8和MCP-1的浓度(美国R&D公司试剂盒)。COPD患者中表达LFA-1和ICAM-1的淋巴细胞百分比分别为:33.9±23.8%和25.8±12.2%;哮喘患者中为23.9±12.1%和15.3±4.42%;对照组中为14.2±10%和5.2±1.6%。观察到COPD患者与对照组之间表达LFA-1和ICAM-1的淋巴细胞百分比存在显著差异。IL-8的浓度在COPD中为2306±1501 pg/ml,在哮喘中为233±27.3 pg/ml,在对照组中为64±28.7 pg/ml(p<0.05)。MCP-1的浓度在COPD中为768.9±668.1 pg/ml,在哮喘中为126.8±30.8 pg/ml,在对照组中为83.0±16.4 pg/ml(p<0.05)。仅在COPD患者中观察到表达LFA-1的淋巴细胞与IL-8浓度之间(r=+0.5,p<0.05)、表达LFA-1的淋巴细胞与MCP-1浓度之间(r=+0.5,p<0.05)以及表达ICAM-1的淋巴细胞与MCP-1浓度之间(r=+0.4,p<0.05)存在相关性。我们的数据表明,LFA-1和ICAM-1是白细胞募集过程中的重要分子,并且与IL-8和MCP-1一起可能在哮喘尤其是COPD的炎症发病机制中发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验